Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
Authors
Keywords
Osteosarcoma, miR-126, Epigallocatechin-3-gallate, Sensitization, Apoptosis
Journal
World Journal of Surgical Oncology
Volume 12, Issue 1, Pages 383
Publisher
Springer Nature
Online
2015-06-18
DOI
10.1186/1477-7819-12-383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of miR-17 and miR-20a by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S
- (2014) H. Weng et al. CANCER RESEARCH
- A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance
- (2014) Xiuling Xu et al. CARCINOGENESIS
- MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1
- (2013) Fang Ji et al. BONE
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer
- (2013) Dominique Trudel et al. GYNECOLOGIC ONCOLOGY
- Resveratrol Inhibits Hydrogen Peroxide-Induced Apoptosis in Endothelial Cells via the Activation of PI3K/Akt by miR-126
- (2013) Xiang-qian Sui et al. Journal of Atherosclerosis and Thrombosis
- Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells
- (2013) Cornelia Braicu et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
- (2013) Guangyi Zhao et al. PLoS One
- Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications
- (2013) Munkyong Pae et al. Food & Function
- MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells
- (2012) L. Fan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells
- (2012) Di Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Loss of miR-126 is crucial to pancreatic cancer progression
- (2012) Adam E Frampton et al. Expert Review of Anticancer Therapy
- Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression
- (2012) Sung Un Kang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
- (2011) Brahma N. Singh et al. BIOCHEMICAL PHARMACOLOGY
- EGCG Inhibits the Invasion of Highly Invasive CL1-5 Lung Cancer Cells through Suppressing MMP-2 Expression via JNK Signaling and Induces G2/M Arrest
- (2011) Yea-Tzy Deng et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Anticancer and Anti-inflammatory Effects of Cysteine Metabolites of the Green Tea Polyphenol, (−)-Epigallocatechin-3-gallate
- (2010) Joshua D. Lambert et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (−)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells
- (2009) Chieh-Wen Cheng et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started